Open Access

ARTICLE

HNRNPC as a pan-cancer biomarker and therapeutic target involved in tumor progression and immune regulation

YUEZHOU ZHANG^1,#, ZHAO ZHANG^2,#, JINXIN DONG¹, CHANGAN LIU^1,*

1 Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China
2 Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China

* Corresponding Author: CHANGAN LIU. Email:
# These two authors contributed equally to this work